对患有帕金森病的人群进行唱歌干预:系统性审查和元分析
J Yoon Irons1, David Sheffield2
1School of Psychology, University of Derby, Derby, UK y.irons@derby.ac.uk.
BMJ open
|November 25, 2025
概括
唱歌干预措施对患有帕金森病的个体有潜在的益处,改善声响和呼吸功能. 然而,目前的证据有限,需要进一步进行高质量的研究.
科学领域:
- 神经学 神经学
- 语音语言病理学 语言病理学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 显著影响运动,呼吸和沟通功能.
- 唱歌干预越来越多地被探索为PD管理的补充疗法.
- 现有的研究缺乏歌唱的影响和干预实践的全面综合.
研究的目的:
- 进行一项元分析,评估歌唱干预措施对帕金森病的福祉,心理健康和功能结果的影响.
- 检查PD的歌唱干预措施中常见的做法和元素.
主要方法:
- 随机和非随机研究的系统审查和元分析.
- 搜索了四个数据库和谷歌学者到2025年4月3日.
- 使用已建立的质量检查清单评估偏差风险.
主要成果:
- 包括23项研究,540名参与者.
- 在RCT中,唱歌干预显示了声响在统计学上显著的改善 (SMD=0.67),尽管证据质量非常低.
- 综合分析 (包括非RCT) 表明对最大发音时间,声音强度和最大灵感压力产生积极影响,但证据质量非常低.
结论:
- 唱歌干预可以为帕金森病患者提供支持.
- 目前,由于缺乏足够的高质量的证据,无法就唱歌的影响得出明确的结论.
- 更强大的随机对照试验对于确定疗效和指导临床实践至关重要.
相关概念视频
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Heart Failure VII: Nursing Interventions
400
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
400
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Heart Failure VI: Adjunct Therapies
239
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
239


